Quality of care in diabetes: Understanding the guidelines

被引：9

作者：

Bouldin, MJ ^{[1
]}

Low, AK ^{[1
]}

Blackston, JW ^{[1
]}

Duddleston, DN ^{[1
]}

Holman, HE ^{[1
]}

Hicks, GS ^{[1
]}

Brown, CA ^{[1
]}

机构：

[1] Univ Mississippi, Med Ctr, Div Gen Internal Med, Dept Med, Jackson, MS 39216 USA

来源：

AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 2002年 / 324卷 / 04期

关键词：

diabetes; guidelines; quality indicators; review;

D O I：

10.1097/00000441-200210000-00006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We are in the midst of a global pandemic of diabetes. Despite the increasing burden of the disease, measurements of quality repeatedly show poor adherence to or implementation of current guidelines for diabetes care. This article will provide a brief review of the most significant randomized controlled clinical trials relevant to the current guidelines and then discuss essential treatment goals and the evidence that supports them. Several practical clinical questions related to the implementation of modern diabetes guidelines will be raised and answered. Finally, reasons for the poor quality performance observed will be examined.

引用

页码：196 / 206

页数：11

共 60 条

[1] Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes [J].

Abraira, C ;

Colwell, J ;

Nuttall, F ;

Sawin, CT ;

Henderson, W ;

Comstock, JP ;

Emanuele, NV ;

Levin, SR ;

Pacold, I ;

Lee, HS ;

Silbert, CK ;

Cxypoliski, R ;

Vasquez, M ;

Kernan, D ;

Niewoehner, C ;

Backes, M ;

Bradley, M ;

Crow, R ;

Rubino, F ;

Bushnell, D ;

Pfeifer, M ;

Service, FJ ;

Howard, B ;

Chew, E ;

Hoogwerf, B ;

Seigel, D ;

Clark, CM ;

Olefsky, JM ;

Porte, D ;

Sussman, KE ;

Johnson, N ;

Christine, B ;

Tir, K ;

Sather, M ;

Day, P ;

Morgan, N ;

Deykin, D ;

Gold, J ;

Huang, P .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) :181-188

[2] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].

ALTMAN, R ;

CARRERAS, L ;

DIAZ, R ;

FIGUEROA, E ;

PAOLASSO, E ;

PARODI, JC ;

CADE, JF ;

DONNAN, G ;

EADIE, MJ ;

GAVAGHAN, TP ;

OSULLIVAN, EF ;

PARKIN, D ;

RENNY, JTG ;

SILAGY, C ;

VINAZZER, H ;

ZEKERT, F ;

ADRIAENSEN, H ;

BERTRANDHARDY, JM ;

BRAN, M ;

DAVID, JL ;

DRICOT, J ;

LAVENNEPARDONGE, E ;

LIMET, R ;

LOWENTHAL, A ;

MORIAU, M ;

SCHAPIRA, S ;

SMETS, P ;

SYMOENS, J ;

VERHAEGHE, R ;

VERSTRAETE, M ;

ATALLAH, A ;

BARNETT, H ;

BATISTA, R ;

BLAKELY, J ;

CAIRNS, JA ;

COTE, R ;

CROUCH, J ;

EVANS, G ;

FINDLAY, JM ;

GENT, M ;

LANGLOIS, Y ;

LECLERC, J ;

NORRIS, J ;

PINEO, GF ;

POWERS, PJ ;

ROBERTS, R ;

SCHWARTZ, L ;

SICURELLA, J ;

TAYLOR, W ;

THEROUX, P .

BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100

[3]

*AM ASS CLIN END, 1999, ENDOCR PRACT, V5, P157

[4]

*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS25

[5]

*AM DIAB ASS, 2001, DIABETES CARE, V24, pS28

[6]

*AM DIAB ASS, 1996, DIAB 1996 VIT STAT

[7]

*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS33

[8]

*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS62

[9]

*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS51

[10]

*AM DIAB ASS, 2001, DIABETES CARE S1, V24, pS56

← 1 2 3 4 5 6 →